Search research articles
Contact Us
Filters
Showing results (171-180 of 179) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 179 results.
Journal of Medical Genetics
|
March 7, 2009
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype
T Kleefstra, W A van Zelst-Stams, W M Nillesen, et al.
Journal of Dental Research
|
November 12, 2016
Novel IRF6 Mutations Detected in Orofacial Cleft Patients by Targeted Massively Parallel Sequencing
K D Khandelwal, N Ishorst, H Zhou, et al.
Journal of Medical Genetics
|
January 8, 2008
Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis
B W M van Bon, D A Koolen, R Borgatti, et al.
NPJ Genomic Medicine
|
November 16, 2021
Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
R Koster, R D Brandão, D Tserpelis, et al.
Journal of Medical Genetics
|
April 7, 2009
Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function
F Lacbawan, B D Solomon, E Roessler, et al.
Journal of Medical Genetics
|
July 17, 2008
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome
D A Koolen, A J Sharp, J A Hurst, et al.
Clinical Genetics
|
January 17, 2013
MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study
P Makrythanasis, B W van Bon, M Steehouwer, et al.
Cell
|
November 24, 2001
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
Y Gong, R B Slee, N Fukai, et al.
Journal of Medical Genetics
|
April 18, 2009
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome
B W M van Bon, H C Mefford, B Menten, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 179) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 179 results.
Journal of Medical Genetics
|
March 7, 2009
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype
T Kleefstra, W A van Zelst-Stams, W M Nillesen, et al.
Journal of Dental Research
|
November 12, 2016
Novel IRF6 Mutations Detected in Orofacial Cleft Patients by Targeted Massively Parallel Sequencing
K D Khandelwal, N Ishorst, H Zhou, et al.
Journal of Medical Genetics
|
January 8, 2008
Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis
B W M van Bon, D A Koolen, R Borgatti, et al.
NPJ Genomic Medicine
|
November 16, 2021
Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
R Koster, R D Brandão, D Tserpelis, et al.
Journal of Medical Genetics
|
April 7, 2009
Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function
F Lacbawan, B D Solomon, E Roessler, et al.
Journal of Medical Genetics
|
July 17, 2008
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome
D A Koolen, A J Sharp, J A Hurst, et al.
Clinical Genetics
|
January 17, 2013
MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study
P Makrythanasis, B W van Bon, M Steehouwer, et al.
Cell
|
November 24, 2001
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
Y Gong, R B Slee, N Fukai, et al.
Journal of Medical Genetics
|
April 18, 2009
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome
B W M van Bon, H C Mefford, B Menten, et al.
Page
of 18